AI assistant
RESMED INC — Director's Dealing 2014
May 5, 2014
30071_dirs_2014-05-05_5436d9d6-ab8d-46e9-bb93-0aad81e201cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-05-01
Reporting Person: FARRELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-01 | ResMed Common Stock | M | 25000 | $12.468 | Acquired | 329990 | Direct |
| 2014-05-01 | ResMed Common Stock | S | 25000 | $49.801 | Disposed | 304990 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-01 | ResMed Common Stock Options | $12.468 | M | 25000 | Disposed | 2015-01-20 | ResMed Common Stock (25000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: This transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: Represents date options first became exercisable. Options vest 1/3 per year on the anniversary of the grant.
F3: This transaction was executed in multiple trades at prices ranging from $49.65 to $50.00. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction as effected upon request to the SEC staff, the issuer or the security holder of the issuer.